Outlook Therapeutics (OTLK) Stock: Buy, Sell, or Hold?
OTLK - Outlook Therapeutics, Inc. Common Stock
$0.52
0.00 (0.74%)
▲
5d:
-0.56%
30d:
-16.74%
90d:
-48.29%
HOLD
MODERATE Confidence
Analysis Updated: Oct 27, 2026 12:00 AM ET
Earnings: Dec 18, 2026
Get Alerted When OTLK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: OTLK shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: OTLK shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: OTLK is currently trading at $0.52, which is considered slightly low relative to its 30-day fair value range of $0.52 to $0.64.
Technical Outlook: Technically, OTLK is in a strong downtrend. Immediate support is located at $0.44, while resistance sits at $0.60.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.03 (+879.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OTLK is in a strong downtrend. Immediate support is located at $0.44, while resistance sits at $0.60.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.03 (+879.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.52 -
$0.64
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 879.0% below Wall St target ($5.03)
- NEUTRAL: Bottoming setup forming (55/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$0.52 -
$0.64
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.44
Resistance Level
$0.60
Current Trend
Strong Downtrend
Technical data as of
Oct 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.28
Wall Street Target
$5.03
(+879.0%)
Revenue Growth (YoY)
-99.4%
Share & Embed Analysis
Last updated: October 27, 2026 2:33 PM ET
Data refreshes hourly during market hours. Next update: 3:33 PM
Data refreshes hourly during market hours. Next update: 3:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OTLK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$92 | 67 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
23 analysts |
$108 | 52 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$280 | 43 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$130 | 58 HOLD |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
15 analysts |
$108 | 70 BUY |
